Anti-carcinogenic effects of the flavonoid luteolin

Molecules

Volumn 13, Issue 10, 2008, Pages 2628-2651

  Seelinger, Günter ^a   Merfort, Irmgard ^b   Wölfle, Ute ^c   Schempp, Christoph M ^c  

^a Medical and Pharmaceutical Services   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cancer; Epidemiology; Luteolin; Pharmacology

Indexed keywords

ANTINEOPLASTIC AGENT; FLAVONOID; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW; TUMOR CELL LINE;

ANIMALS; ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; HUMANS; LUTEOLIN; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 55249085887     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules13102628     Document Type: Review

References (87)

1. Block, G.; Patterson, B.; Subar, A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992, 18, 1-29.
2. Huang, D.; Ou, B.; Prior, R.L. The chemistry behind antioxidant capacity assays. J. Agric. Food. Chem. 2005, 53, 1841-1856.
3. Soobrattee, M.A.; Neergheen, V.S.; Luximon-Ramma, A.; Aruoma, O.I.; Bahorun, T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat. Res. 2005, 579, 2000-2013.
4. Seelinger, G.; Merfort, I.; Schempp, C.M. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin, a flavone from the Dyer's weld Reseda luteola L. Planta Med. 2008, accepted.
5. ++ ions: implications for their anti-oxidant properties. Biochem. J. 1998, 1173-1178.
6. Heilmann, J.; Merfort, I. Aktueller Kenntnisstand zum Metabolismus von Flavonoiden. II. Resorption und Metabolismus von Flavonen, Flavanonen, Flavanen, Procyanidinen und Isoflavonoiden. Pharm. Uns. Zeit 1998, 27, 173-183.
7. Wittemer, S.M.; Ploch, M.; Windeck, T.; Müller, S.C.; Drewelow, B.; Derendorf, H.; Veit, M. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine 2005, 12, 28-38.
8. Boersma, MG.; van der Woude, H.; Bogaards, J.; Boeren, S.; Vervoort, J.; Cnubben, N.H.; van Iersel, M.L.; van Bladeren, P.J.; Rietjens, I.M. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 2000, 15, 662-670.
9. Shimoi, K.; Nakayama, T. Glucuronidase deconjugation in inflammation. Methods Enzymol. 2005, 400, 263-272.
10. Merfort, I.; Heilmann, J; Hagedorn-Leweke, U.; Lippold, B.C. In vivo skin penetration studies on chamomile flavones. Pharmazie 1994, 49, 509-511.
11. Chen, L.; Zhuang, H.-Y. Cancer preventive effects of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007, 12, 946-957.
12. Fotsis, T.; Pepper, M.S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wähälä, K.; Montesano, R.; Schweigerer, L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997, 57, 2916-2921.
13. Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci. Biotechnol. Biochem. 1999, 63, 896-899.
14. Post, J.F.; Varma R.S. Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-Cz cells. Cancer Lett. 1992, 67, 207-213.
15. Hirobe, Ch.; Quiao, Z.-S.; Takeya, K.; Itokawa, H. Cytotoxic flavonoids from Vitex agnus castus. Phytochemistry 1997, 46, 521-524.
16. Cherng, J.M.; Shieh, D.E.; Chiang, W.; Chang, M.Y.; Chiang, LC. Chemopreventive effects of minor dietary constituents in common foods on human cancer cells. Biosci. Biotechnol. Biochem. 2007, 71, 1500-1504.
17. Takahashi, T.; Kobori, M.; Shinmoto, H.; Tsushida, T. Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Biosci. Biotechnol. Biochem. 1998, 62, 2199-2204.
18. Ko, W.G; Kang, T.H.; Lee, S.J.; Kim, Y.C.; Lee, BH. Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells. Phytother. Res. 2002, 16, 295-298.
19. Chang, H.; Mi, M.T.; Gu, Y.Y.; Yuan, J.L.; Ling, W.H.; Lin, H. Effects of flavonoids with different structures on proliferation of leukemia cell line HL-60 [Article in Chinese]. Ai Zheng 2007, 26, 1309-1314.
20. Huang, Y.T.; Hwang, J.J.; Lee, P.P.; Ke, F.C.; Huang, J.H.; Kandaswami, D.; Middleton, E. Jr.; Lee, M.T. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A 431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol. 1999, 128, 999-1010.
21. Kim, J.H.; Lee, E.O.; Lee, H.J.; Ku, J.S.; Lee, M.H.; Yang, D.C.; Kim, S.H. Caspase activation and extracellular signal-regulated kinase/Akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells. Ann. N. Y. Acad. Sci. 2007, 1095, 598-611.
22. Knowles, L.M.; Zigrossi, D.A.; Tauber, R.A.; Hightower, C.; Milner, J.A. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 2000, 38, 116-122.
23. Lim, D.Y.; Jeong, Y.; Tyner, A.L.; Jung, H.Y. P. Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G66-G75.
24. Plaumann, B.; Fritsche, M.; Rimpler, H.; Brandner, G.; Hess, R.D. Flavonoids activate wild-type p53. Oncogene 1996, 13, 1605-1614.
25. Chang, J.; Hsu, Y.; Kuo, P.; Kuo, Y.; Chiang, L.; Lin, C. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci. 2005, 76, 1883-1893.
26. Leung, H.W; Wu, C.H.; Lin, C.H.; Lee, H.Z. Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. Eur. J. Pharmacol. 2005, 508, 77-83.
27. Wang, T.; Zhang, J.C.; Chen, Y.; Huang, F.; Yang, M.S.; Xiao, P.G. Comparison of antioxidative and antitumor activities of six flavonoids from Epimedium koreanum [Article in Chinese]. Zhongguo Zhong Yao Za Zhi 2007, 32, 715-718.
28. Pettit, G.R.; Hoard, M.S.; Doubek, D.L.; Schmidt, J.M.; Pettit, R.K.; Tackett, L.P.; Chapuis, JCh. The cancer cell growth inhibitory constituents of Terminalia arjuna (Combretaceae). J. Ethnopharmacol. 1996, 53, 57-63.
29. Leung, H.W.; Kuo, C.L.; Yang, W.H.; Lin, C.H.; Lee, H.Z. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur. J. Pharmacol. 2006, 534, 12-18.
30. Makino, T.; Ono, T.; Muso, E.; Honsa, G. Inhibitory effect of Perilla frutescens and its phenolic constituents on cultured murine mesangial cell proliferation. Planta Med. 1998, 64, 541-545.
31. Mori, A.; Nishino, Ch.; Enoki, N.; Tawata, S. Cytotoxicity of plant flavonoids against HeLa cells. Phytochemistry 1988, 27, 1017-1020.
32. Woerdenbag, H.; Merfort, I.; Passreiter, C.M.; Schmidt, Th.J.; Willuhn, G.; van Uden, W.; Pras, N.; Kampinga, H.H.; Konings, A.W. Cytotoxicity of flavonoids and sesquiterpene lactones from arnica species against the GLC4 and the COLO 320 cell lines. Planta Med. 1994, 60, 434-437.
33. (WAF1/CIP1) expression with rapamycin. Mol. Cancer. Ther. 2007, 6, 2127-2138.
34. Selvendiran, K.; Koga, H.; Ueno, T.; Yoshida, T.; Maeyama, M.; Torimura, T.; Yano, H.; Kojiro, M.; Sata, M.. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res. 2006, 66, 4826-4834.
35. Chiu. F.L.; Lin, J.K. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Prostate 2008, 68, 61-71.
36. Fang, J.; Zhou, Q.; Shi, X.L.; Jiang, B.H. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis 2007, 28, 713-723.
37. Manju, V.; Nalini, N. Protective role of luteolin in 1,2- dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem. Funct. 2007, 25, 189-194.
38. 3H] estradiol binding sites and prostatic cancer cell proliferation. Int. J. Oncol. 1997, 11, 1311-1319.
39. van der Bij, G.J.; Bögels.; Oosterling, S.J.; Kroon, J.; Schuckmann, D.T.; de Vries, H.E.; Meijer, S.; Beelen, R.H.; van Egmond, M. Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastases. Cancer Lett. 2008, Jan 8 2008 [Epub ahead of print].
40. Ueda, H.; Yamazaki, C.; Yamazaki, M. Inhibitory effect of Perilla leaf extract and luteolin on mouse skin tumor promotion. Biol. Pharm. Bull. 2003, 26, 560-563.
41. Plaschke, K. Composition comprising one or more flavonoids, method of obtaining such composition and use thereof as UV-absorbing agent. US Pat. 6409996 B1, 2002.
42. Gers-Barlag, H.; Kummerfeld, D.E.; Knüppel, A.; Müller, A.; Rümpel, D.E.; Stäb, F.; Dörschner, A.; Schönrock, U. Wirkstoffkombination aus sulfonierten UV-Filtersubstanzen und Flavonderivaten und/oder Flavanonderivaten, insbesondere Flanonoiden, sowie kosmetische Zubereitungen, solche Wirkstoffkombinationen enthaltend. Pat. Appl. DE 199 23 712 A 1, 2000.
43. Horváthová, K.; Novotný, L.; Vachá lková, A. The free radical scavenging activity of four flavonoids determined by the comet assay. Neoplasma 2003, 50, 291-295.
44. Horváthová, K.; Novotný, L.; Tóthová, D.; Vachálková, A. Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562. Neoplasma 2004, 51, 395-399.
45. Horváthová, K.; Chalupa, L.; Sebova, D.; Tóthová, D.; Vachálková, A. Protective effect of quercetin and luteolin in human melanoma HMB-2 cells. Mut. Res. 2005, 565, 105-112.
46. Noroozi, M.; Angerson, W.J.; Lean, M.E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Nutr. 1998, 67, 1210-1218.
47. Steffan, B. Inhaltsstoffe aus Pflanzen der indonesischen Volksmedizin (Jamu): Isolierung, Identifizierung, und Charakterisierung der antioxidativen Eigenschaften. Doctoral thesis. Heinrich Heine Universität: Düsseldorf, Germany, 2005.
48. Shimoi, K.; Masuda, S.; Shen, B.; Furugori, M.; Kinae, N. Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis 1994, 15, 2669-2672.
49. Sharma, V.; Mishra, M.; Ghosh, S.; Tewari, R.; Basu, A.; Seth, P.; Sen, E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull. 2007, 73, 55-63.
50. Samy, R.P.; Gopalakrishnakone, P.; Ignacimuthu, S. Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Chem. Biol. Interact. 2006, 164, 1-14.
51. Manju, V.; Nalini, N. Chemopreventive potential of luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine. Ital. J. Biochem. 2005, 54, 268-275.
52. Choi. J.S.; Park, K.Y.; Moon, S.H.; Rhee, S.H.; Young, H.S. Antimutagenic effect of plant flavonoids in the Salmonella assay system. Arch. Pharm. Res. 1994, 17, 71-75.
53. Taj, S.; Nagarajan, B. Inhibition by quercetin and luteolin of chromosomal alterations induced by salted, deep-fried fish and mutton in rats. Mutat. Res. 1996, 369, 97-106.
54. Li, Y.C.; Hung, C.F.; Yeh, F.T.; Lin, J.P.; Chung, J.G. Luteolin-inhibited arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human and mouse leukemia cells. Food Chem. Toxicol. 2001, 39, 641-647.
55. Lu, K.H.; Lin, K.L.; Yang, C.C.; Hsia, T.C.; Hsiao, Y.M.; Chou, M.C.; Ho, H.C.; Chung, J.G. The effect of paclitaxel on gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in human leukemia HL-60 cells. Food Chem. Toxicol. 2002, 40, 705-713.
56. Chen, J.C.; Chung, J.G.; Lin, K.M. Effects of luteolin on arylamine N-acetyltransferase activity in human liver tumour cells. Cytobios 2000, 102, 95-106.
57. Su, C.C.; Chen, G.W.; Yeh, C.C.; Yang, M.D.; Hung, C.F.; Chung, J.G. Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene accompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line. Anticancer Res. 2003, 23, 355-362.
58. Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem. Biol. Interact. 2006, 160, 123-133.
59. Lansky, E.P.; Harrison, G.; Froom, P.; Jiang, W.G. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest. New Drugs 2005, 23, 121-122.
60. Yamashita, N.; Kawanishi, S. Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin. Free Radic. Res. 2000, 33, 623-633.
61. Cantero, G.; Campanella, C.; Mateos, S.; Cortés, F. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Mutagenesis 2006, 21, 321-325.
62. Sugimura, T.; Nagao, M.; Matsushima, T, et al. Mutagenicity of flavone derivatives. Proc. Jpn. Acad. 1977, 53, 194-197.
63. van der Hoeven, J.C.M.; Bruggeman, I.M.; Debets, F.M.H. Genotoxicity of quercetin in cultured mammalian cells. Mutat. Res. 1984, 136, 9-12.
64. Chowdhury, A.R.; Sharma, S.; Mandal, S.; Goswami, A.; Mukhopadhyay, S.; Majumder, H.K. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase. Biochem. J. 2002, 366, 653-661.
65. Ruiz, P.A.; Haller, D. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J. Nutr. 2006, 136, 664-671.
66. Agullo. G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Rémésy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1997, 53, 1649-1657.
67. Liu, W.; Liang, N.C.; Huang, R.B.; Effect of three flavones on enzyme activity of recombinant human phosphoinositide 3-kinase p110beta catalytic subunit [Article in Chinese]. Zhong Yao Cai. 2006, 29, 33-36.
68. Shi, R.; Huang, Q.; Zhu, X.; Ong, Y.B.; Zhao, B.; Lu, J.; Ong, C.N.; Shen, H.M. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol. Cancer Ther. 2007, 6, 1338-1347.
69. Han, H.Y.; Shan, S.; Zhang, X.; Wang, N.L.; Lu, X.P.; Yao, X.S. Down-regulation of prostate specific antigen in LNCaP cells by flavonoids from the pollen of Brassica napus L. Phytomedicine 2007, 14, 338-343.
70. Cheng, A.C.; Huang, T.C.; Lai, C.S.; Pan, M.H. Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells. Eur. J. Pharmacol. 2005, 509, 1-10.
71. Lee, H.J.; Wang, C.J.; Kuo, H.C.; Chou, F.P.; Jean, L.F.; Tseng, T.H. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol. Appl. Pharmacol. 2005, 203, 124-131.
72. Horinaka, M.; Yoshida, T.; Shiraishi, T.; Nakata, S.; Wakada, M.; Nakanishi, R.; Nishino, H.; Matsui, H.; Sakai, T. Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene 2005, 24, 7180-7189.
73. Michels, G.; Wätjen, W.; Niering, P.; Steffan, B.; Thi, Q.H.; Chovolou, Y.; Kampkötter, A.; Bast, A.; Proksch, P.; Kahl, R. Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology 2005, 206, 337-348.
74. Shi, R.X.; Ong, C.N.; Shen, H.M. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Cancer Res. 2005, 65, 7815-7823.
75. Lupu, R.; Menendez, J.A. Pharmacological inhibitors of Fatty Acid Synthase (FASN) - catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr. Pharm. Biotechnol. 2006, 7, 483-493.
76. van Zanden, J.J.; Geraets, L.; Wortelboer, H.M.; van Bladeren, P.J.; Rietjens, I.M.C.M.; Cnubben, N.H.P. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem. Pharmacol. 2004, 67, 1607-1617.
77. Graefe, E.U.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of the flavonols quercetin in humans. Int. J. Clin. Pharmacol. Ther. 1999, 37, 219-233.
78. nd release, 2007. http://www.ars.usda.gov/nutrientdata.
79. Bosetti, C.; Spertini, L.; Parpinel, M.; Gnagnarella, P.; Lagiou, P.; Negri, E.; Franceschi, S.; Montella, M.; Peterson, J.; Dwyer, J.; Giacosa, A.; La Vecchia, C. Flavonoids and breast cancer risk in Italy. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 805-808.
80. Peterson, J.; Lagiou, P.; Samoli, E.; Lagiou, A.; Katsouyanni, K.; La Vecchia, C.; Dwyer, J.; Trichopoulos, D. Flavonoid intake and breast cancer risk: a case--control study in Greece. Br. J. Cancer 2003, 89, 1255-1259.
81. Fink, B.N.; Gaudet, M.M.; Britton, J.A.; Abrahamson, P.E.; Teitelbaum, S.L.; Jacobson, J.; Bell, P.; Thomas, J.A; Kabat, G.C.; Neugut, A.I.; Gammon, M.D. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Res. Treat. 2006, 98, 199-208.
82. Fink, B. N.; Steck, S.E.; Wolff, M.S.; Britton, J. A.; Kabat, G.C.; Gaudet, M.M.; Abrahamson, P.E.; Bell, P.; Schroeder, J.C.; Teitelbaum, S.L.; Neugut, A.I.; Gammon, M.D. Dietary Flavonoid Intake and Breast Cancer Survival among Women on Long Island. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 2285-2292.
83. Rossi, M.; Negri, E.; Talamini, R.; Bosetti, C.; Parpinel, M.; Gnagnarella, P.; Franceschi, S.; Dal Maso, L.; Montella, M.; Giacosa, A.; La Vecchia, C. Flavonoids and Colorectal Cancer in Italy. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1555-1558.
84. Bosetti, C.; Rossi, M.; McLaughlin, JK; Negri, E.; Talamini, R.; Lagiou, P.; Montella, M.; Ramazzotti, V.; Franceschi, S.; LaVecchia, C. Flavonoids and the risk of renal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 98-101.
85. Garcia-Closas, R.; Agudo, A.; Gonzalez, C.A.; Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr. Cancer 1998, 32, 154-158.
86. Neuhouser, M.L. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr. Cancer. 2004, 50, 1-7.
87. Gates, M.A.; Tworoger, S.S.; Hecht, J.L.; De Vivo, I.; Rosner, B.; Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int. J. Cancer. 2007, 121, 2225-2232.